This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Immunome, Inc.. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Iraz T Aydin: Innovator in Cancer Therapeutics
Introduction
Iraz T Aydin is a notable inventor based in San Carlos, CA, who has made significant contributions to the field of cancer therapeutics. His work primarily focuses on the development of antibodies that target specific tumor tissues, providing new avenues for treatment.
Latest Patents
Iraz T Aydin holds a patent for EphA2 antibodies. These antibodies are designed to bind preferentially to tumor tissue rather than normal tissue, specifically targeting the EphA2 protein. The applications of these antibodies include methods for inducing an immune response and inhibiting tumor cell growth. Additionally, the patent outlines methods for producing these antibodies, showcasing Aydin's innovative approach to cancer treatment.
Career Highlights
Aydin is currently associated with Immunome, Inc., where he continues to advance his research in antibody development. His work has the potential to significantly impact cancer therapies, offering hope for more effective treatments.
Collaborations
Iraz T Aydin collaborates with talented professionals in his field, including Alexander Scholz and Anne Ye. These collaborations enhance the research and development of innovative therapeutic solutions.
Conclusion
Iraz T Aydin's contributions to the field of cancer therapeutics through his patent on EphA2 antibodies exemplify the importance of innovation in medicine. His work not only advances scientific knowledge but also holds promise for improving patient outcomes in cancer treatment.